跳至主要内容
临床试验/TCTR20200915003
TCTR20200915003已完成3 期

Quality Of Life in patients using intravenous versus oral iron

Shahrekord University of Medical Sciences0 个研究点目标入组 79 人开始时间: 2020年9月15日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
79

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 N/A (No limit) 至 0 N/A (No limit)(—)
性别
All

入选标准

  • The criteria for including the study were: anemia secondary to malignancy and chemotherapy, the patient's hemoglobin 1 to 4 degrees based on the NCI system, serum ferritin level lower than 15, the Karnofsky performance status scale (an assessment tool for functional impairment) greater than or equal to 70%, and in remission stage for those cases with hematological malignancies.

排除标准

  • Those patients with the following criteria were excluded: anemia due to other causes than malignancy, suffering from digestive disorders caused by oral iron intake or gastrointestinal bleeding, gastric cancer, total gastrostomy, lack of response to more than 20% of questions in the questionnaire, unwillingness of the patient to continue cooperation during the study, serum ferritin level greater than 500, patient death due to complications of the illness or treatment during the study, banning from Eprex administration due to thromboembolic events and systolic blood pressure more than 160 mm Hg during the study or any infection

研究者

相似试验